Top

Supportive Care in Cancer

Published in:

01-11-2017 | Original Article

Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer

Authors: J. C. Faivre, V. Adam, V. Block, M. Metzger, J. Salleron, S. Dauchy

Published in: Supportive Care in Cancer | Issue 11/2017

Abstract

Purpose

The study’s purpose was to develop practical guidelines for assessment and management of refusal of treatment by adults afflicted with cancer.

Methods

The French Association for Supportive Care in Cancer and the French Society for Psycho-oncology gathered a task force that applied a consensus methodology to draft guidelines studied predisposing situations, the diagnosis, regulatory aspects, and the management of refusal of treatment by adults afflicted with cancer.

Results

We propose five guidelines: (1) be aware of the conditions/profiles of patients most often associated with refusal of treatment so as to adequately underpin the care and support measures; (2) understand the complexity of the process of refusal and knowing how to accurately identify the type and the modalities of the refused treatments; (3) apply a way to systematically analyze refusal, thereby promoting progression from a situation of disaccord toward a consensual decision; (4) devise procedures, according to the legal context, to address refusal of treatment that safeguards the stakeholders in situations of sustained disaccord; and (5) know the indications for ethical collective decision-making.

Conclusion

The quality of the relationship between patients and health professionals, and the communication between them are essential components involved in reaching a point of consent or refusal of treatment. A process of systematic analysis of refusal is recommended as the only way to ensure that all of the physiological, psychological, and contextual elements that are potentially involved are taken into account.

Liu C-Y, Chen WT-L, Kung P-T et al (2014) Characteristics, survival, and related factors of newly diagnosed colorectal cancer patients refusing cancer treatments under a universal health insurance program. BMC Cancer 14:446. doi:10.1186/1471-2407-14-446 CrossRefPubMedPubMedCentral

Aizer AA, Chen M-H, Parekh A et al (2014) Refusal of curative radiation therapy and surgery among patients with cancer. Int J Radiat Oncol Biol Phys 89:756–764. doi:10.1016/j.ijrobp.2014.03.024 CrossRefPubMed

Li P, Li F, Fang Y et al (2013) Efficacy, compliance and reasons for refusal of postoperative chemotherapy for elderly patients with colorectal cancer: a retrospective chart review and telephone patient questionnaire. PLoS One 8:e55494. doi:10.1371/journal.pone.0055494 CrossRefPubMedPubMedCentral

Puts MTE, Tapscott B, Fitch M et al (2015) A systematic review of factors influencing older adults’ decision to accept or decline cancer treatment. Cancer Treat Rev 41:197–215. doi:10.1016/j.ctrv.2014.12.010 CrossRefPubMed

Berg WA, Blume JD, Adams AM et al (2010) Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 254:79–87. doi:10.1148/radiol.2541090953 CrossRefPubMed

Rothman MD, Van Ness PH, O’Leary JR, Fried TR (2007) Refusal of medical and surgical interventions by older persons with advanced chronic disease. J Gen Intern Med 22:982–987. doi:10.1007/s11606-007-0222-4 CrossRefPubMedPubMedCentral

Sinding C, Wiernikowski J (2009) Treatment decision making and its discontents. Soc Work Health Care 48:614–634. doi:10.1080/00981380902831303 CrossRefPubMed

Kreling B, Figueiredo MI, Sheppard VL, Mandelblatt JS (2006) A qualitative study of factors affecting chemotherapy use in older women with breast cancer: barriers, promoters, and implications for intervention. Psychooncology 15:1065–1076. doi:10.1002/pon.1042 CrossRefPubMed

Ward-Smith P (2003) Brachytherapy for prostate cancer: the patient’s perspective. Urol Nurs 23:213–217PubMed

10.

Anchisi S, Anchisi A (2008) Going through chemotherapy: an age-revealing process. Bull Cancer (Paris):F44–F50. doi:10.1684/bdc.2007.0532

11.

Schwam ZG, Husain Z, Judson BL (2015) Refusal of postoperative radiotherapy and its association with survival in head and neck cancer. Radiother Oncol 117:343–350. doi:10.1016/j.radonc.2015.10.013 CrossRefPubMed

12.

Richert-Boe KE, Weinmann S, Shapiro JA et al (2008) Racial differences in treatment of early-stage prostate cancer. Urology 71:1172–1176. doi:10.1016/j.urology.2007.10.010 CrossRefPubMed

13.

Chen SJ, Kung P-T, Huang KH et al (2015) Characteristics of the delayed or refusal therapy in breast cancer patients: a longitudinal population-based study in Taiwan. PLoS One 10:e0131305. doi:10.1371/journal.pone.0131305 CrossRefPubMedPubMedCentral

14.

Puts MTE, Monette J, Girre V et al (2010) Characteristics of older newly diagnosed cancer patients refusing cancer treatments. Support Care Cancer 18:969–974. doi:10.1007/s00520-010-0883-0 CrossRefPubMed

15.

Cykert S, Dilworth-Anderson P, Monroe MH et al (2010) Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 303:2368–2376. doi:10.1001/jama.2010.793 CrossRefPubMedPubMedCentral

16.

Huang H-L, Kung P-T, Chiu C-F et al (2014) Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan. PLoS One 9:e101731. doi:10.1371/journal.pone.0101731 CrossRefPubMedPubMedCentral

17.

Ciambrone D (2006) Treatment decision-making among older women with breast cancer. J Women Aging 18:31–47. doi:10.1300/J074v18n04_04 CrossRefPubMed

18.

Sanders T, Skevington S (2004) Participation as an expression of patient uncertainty: an exploration of bowel cancer consultations. Psychooncology 13:675–688. doi:10.1002/pon.779 CrossRefPubMed

19.

Sharf BF, Stelljes LA, Gordon HS (2005) ‘A little bitty spot and I’m a big man’: patients’ perspectives on refusing diagnosis or treatment for lung cancer. Psychooncology 14:636–646. doi:10.1002/pon.885 CrossRefPubMed

20.

Tang S-W, Parker H, Winterbottom L et al (2011) Early primary breast cancer in the elderly—pattern of presentation and treatment. Surg Oncol 20:7–12. doi:10.1016/j.suronc.2009.07.004 CrossRefPubMed

21.

Verkooijen HM, Fioretta GM, Rapiti E et al (2005) Patients’ refusal of surgery strongly impairs breast cancer survival. Ann Surg 242:276–280CrossRef

22.

Chouliara Z, Miller M, Stott D et al (2004) Older people with cancer: perceptions and feelings about information, decision-making and treatment—a pilot study. Eur J Oncol Nurs 8:257–261. doi:10.1016/j.ejon.2003.12.010 CrossRefPubMed

23.

Crooks DL (2001) Older women with breast cancer: new understandings through grounded theory research. Health Care Women Int 22:99–114. doi:10.1080/073993301300003108 CrossRefPubMed

24.

Davison BJ, Oliffe JL, Pickles T, Mroz L (2009) Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol Nurs Forum 36:89–96. doi:10.1188/09.ONF.89-96 CrossRefPubMed

25.

Denberg TD, Melhado TV, Steiner JF (2006) Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer 107:620–630. doi:10.1002/cncr.22033 CrossRefPubMed

26.

Docherty A, Brothwell CPD, Symons M (2007) The impact of inadequate knowledge on patient and spouse experience of prostate cancer. Cancer Nurs 30:58–63CrossRef

27.

White MA, Verhoef MJ, Davison BJ et al (2008) Seeking mind, body and spirit healing—why some men with prostate cancer choose CAM (complementary and alternative medicine) over conventional cancer treatments. Integr Med Insights 3:1–11CrossRef

28.

Lim F, Glynne-Jones R (2011) Chemotherapy/chemoradiation in anal cancer: a systematic review. Cancer Treat Rev 37:520–532. doi:10.1016/j.ctrv.2011.02.003 CrossRefPubMed

29.

Oscarsson MG, Wijma BE, Benzein EG (2008) “I do not need to... I do not want to... I do not give it priority...”—why women choose not to attend cervical cancer screening. Health Expect 11:26–34. doi:10.1111/j.1369-7625.2007.00478.x CrossRefPubMedPubMedCentral

30.

Journal Officiel de la République Française (2002) Loi n° 2002-303 du 4 mars 2002 relative aux droits des malades et à la qualité du système de santé | Legifrance. https://www.legifrance.gouv.fr/affichTexte.do;jsessionid=FAD55642FC6155464B39BF4BB05E8975.tpdjo06v_2?cidTexte=LEGITEXT000005632379&dateTexte=20120918. Accessed 20 Mar 2017

31.

Parker SM, Clayton JM, Hancock K et al (2007) A systematic review of prognostic/end-of-life communication with adults in the advanced stages of a life-limiting illness: patient/caregiver preferences for the content, style, and timing of information. J Pain Symptom Manag 34:81–93. doi:10.1016/j.jpainsymman.2006.09.035 CrossRef

32.

Hewitson P, Austoker J (2005) Part 2: patient information, informed decision-making and the psycho-social impact of prostate-specific antigen testing. BJU Int 95(Suppl 3):16–32CrossRef

33.

Hardwick C, Lawson N (1995) The information and learning needs of the caregiving family of the adult patient with cancer. Eur J Cancer Care (Engl) 4:118–121CrossRef

34.

Hey SP, Truog RD (2015) The question of clinical equipoise and patients’ best interests. AMA J Ethics 17:1108–1115. doi:10.1001/journalofethics.2015.17.12.ecas1-1512 CrossRefPubMed

35.

Nishimura A, Carey J, Erwin PJ et al (2013) Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials. BMC Med Ethics 14:28. doi:10.1186/1472-6939-14-28 CrossRefPubMedPubMedCentral

36.

Jefford M, Moore R (2008) Improvement of informed consent and the quality of consent documents. Lancet Oncol 9:485–493. doi:10.1016/S1470-2045(08)70128-1 CrossRefPubMed

37.

Foreman MD, Mion LC, Tryostad L, Fletcher K (1999) Standard of practice protocol: acute confusion/delirium. NICHE Faculty. Geriatr Nurs N Y N 20:147–152CrossRef

38.

Fiske J, Frenkel H, Griffiths J et al (2006) Guidelines for the development of local standards of oral health care for people with dementia. Gerodontology 23(Suppl 1):5–32. doi:10.1111/j.1741-2358.2006.00140.x CrossRefPubMed

39.

Barr J, Fraser GL, Puntillo K et al (2013) Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 41:263–306. doi:10.1097/CCM.0b013e3182783b72 CrossRefPubMed

40.

American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults (2015) Postoperative delirium in older adults: best practice statement from the American Geriatrics Society. J Am Coll Surg 220:136–148.e1. doi:10.1016/j.jamcollsurg.2014.10.019 CrossRef

41.

Crocker TF, Smith JK, Skevington SM (2015) Family and professionals underestimate quality of life across diverse cultures and health conditions: systematic review. J Clin Epidemiol 68:584–595. doi:10.1016/j.jclinepi.2014.12.007 CrossRefPubMed

42.

Stone L, Blashki G (2000) Integrating counselling into general practice. Aust Fam Physician 29:231–235PubMed

43.

Journal Officiel de la République Française (2016) LOI n° 2016-87 du 2 février 2016 créant de nouveaux droits en faveur des malades et des personnes en fin de vie

44.

Alfandre D (2016) Clinical recommendations in medical practice: a proposed framework to reduce bias and improve the quality of medical decisions. J Clin Ethics 27:21–27PubMed

45.

Noritz G (2015) How can we practice ethical medicine when the evidence is always changing? J Child Neurol 30:1549–1550. doi:10.1177/0883073814563141 CrossRefPubMed

Title: Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer
Authors: J. C. Faivre
V. Adam
V. Block
M. Metzger
J. Salleron
S. Dauchy
Publication date: 01-11-2017
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 11/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3762-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2017

Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group

Effectiveness of a standardized patient education program on therapy-related side effects and unplanned therapy interruptions in oral cancer therapy: a cluster-randomized controlled trial

The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers

Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan

Author’s response

Longitudinal perceptions of the side effects of chemotherapy in patients with gynecological cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer